Company
Syntax Bio
| Industry | synthetic biology company programming new cell therapies, expanded its Series A to $14.4M |
|---|
Funding raised
| Company | Round | Date |
|---|---|---|
| Syntax Bio | Series A | 2026-06-22 |
| Syntax Bio | Funding | 2024-09-18 |
Company
| Industry | synthetic biology company programming new cell therapies, expanded its Series A to $14.4M |
|---|
| Company | Round | Date |
|---|---|---|
| Syntax Bio | Series A | 2026-06-22 |
| Syntax Bio | Funding | 2024-09-18 |